title: Amiodarone versus Sotalol and Propafenone for prevention of immediate recurrence of atrial fibrillation after internal cardioversion: importance of P wave analysis.
authors.forename: Bulent
authors.initials: B
authors.lastname: Gorenek
authors.forename: Yuksel
authors.initials: Y
authors.lastname: Cavusoglu
authors.forename: Omer
authors.initials: O
authors.lastname: Goktekin
authors.forename: Alpaslan
authors.initials: A
authors.lastname: Birdane
authors.forename: Gulmira
authors.initials: G
authors.lastname: Kudaiberdieva
authors.forename: Necmi
authors.initials: N
authors.lastname: Ata
authors.forename: Ahmet
authors.initials: A
authors.lastname: Unalir
authors.forename: Bilgin
authors.initials: B
authors.lastname: Timuralp
mesh_terms: D000638:Amiodarone / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000517:prevention & control; D004554:Electric Countershock; D005260:Female; D006801:Humans; D008297:Male; D011405:Propafenone / Q000627:therapeutic use*; D011446:Prospective Studies; D012008:Recurrence; D013015:Sotalol / Q000627:therapeutic use*
chemical_list: D000889:Anti-Arrhythmia Agents; D011405:Propafenone; D013015:Sotalol; D000638:Amiodarone